ASCL1 and small cell lung carcinoma: More recently, Gay et al. proposed a fourth subtype of SCLC‐inflammation (SCLC‐I), with no universal transcriptional features of ASCL1, NEUROD1, POU2F3, but the unique expression of genes that included many immune checkpoint markers and human leukocyte antigen (HLA).4